MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Drug Newswire' source. Sat, 10 Oct 2009 19:30:48 +0100 http://www.medworm.com/index.php?rid=537396&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15793%2F Data Indicate Positive Results Achieved on Safety, Tolerability and Pharmacokinetics ISELIN, N.J., Nov. 14 /PRNewswire-FirstCall/ -- Pharmos Corporation (NASDAQ:PARS) announced today it has completed its initial analysis of data from a recently completed Phase 1 study of its proprietary NanoEmulsion topical drug delivery technology formulated with diclofenac. Diclofenac... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537396 Wed, 11 Apr 2007 17:55:32 +0100 537396 http://www.medworm.com/index.php?rid=537397&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15792%2F SOUTH SAN FRANCISCO, Calif., April 11 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today provided a clinical update on R788, which is currently in ongoing Phase 2 clinical trials in immune thrombocytopenic purpura (ITP), rheumatoid arthritis (RA) and lymphoma patients. R788 is a novel, oral syk kinase inhibitor that blocks the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537397 Wed, 11 Apr 2007 17:39:51 +0100 537397 http://www.medworm.com/index.php?rid=537398&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15791%2F ECUBLENS, Switzerland, April 11 /PRNewswire-FirstCall/ -- Neurochem (International) Limited (Neurochem), a wholly owned subsidiary of Neurochem Inc. (NASDAQ: NRMX; TSX: NRM), announces that it received notification from the United States Food and Drug Administration (FDA) that the action date for FDA's review of the New Drug Application (NDA) for eprodisate... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537398 Wed, 11 Apr 2007 17:38:46 +0100 537398 http://www.medworm.com/index.php?rid=537399&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15790%2F NEW BRUNSWICK, N.J., April 10 /PRNewswire/ -- WellGen, Inc. today announced that it has completed a pivotal study demonstrating that its nutrigenomics technology platform can successfully predict biological activity of natural products in humans. WellGen is a biotechnology company that uses nutrigenomics to discover and develop proprietary functional food ingredients. (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537399 Wed, 11 Apr 2007 17:32:08 +0100 537399 http://www.medworm.com/index.php?rid=537400&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15789%2F PS433540 Shown to Be Well Tolerated and Potentially Suited for Once Daily Administration PRINCETON, N.J., April 10 /PRNewswire-FirstCall/ -- Pharmacopeia (NASDAQ:PCOP) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537400 Wed, 11 Apr 2007 17:30:57 +0100 537400 http://www.medworm.com/index.php?rid=537401&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15788%2F New insights with six month trial with Clarinol(TM) CLA and its effect on weight management CHANNAHON, Ill., April 9 /PRNewswire/ -- This month the British Journal of Nutrition revealed its latest results on Clarinol(TM) CLA. New research shows that Clarinol(TM) CLA reduces fat mass in particular locations on... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537401 Wed, 11 Apr 2007 17:21:47 +0100 537401 http://www.medworm.com/index.php?rid=537402&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15787%2F Chief Scientist to Present Results at 2007 American Association for Cancer Research Annual Meeting First Compound to Protect from both Gastrointestinal and Hematopoietic Damage when Administrated before or after Irradiation CLEVELAND, April 9 /PRNewswire-FirstCall/ -- Cleveland BioLabs, Inc. (NASDAQ:CBLI) , announced today the results of its... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537402 Wed, 11 Apr 2007 17:20:35 +0100 537402 http://www.medworm.com/index.php?rid=537403&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15786%2F Millions of Americans now seeking a safe, effective alternative treatment for IBS CINCINNATI, April 9 /PRNewswire/ -- With the recent Food and Drug Administration discontinuation of a leading prescription drug for constipation associated with irritable bowel syndrome (IBS) and chronic constipation, millions of Americans are now seeking a... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537403 Wed, 11 Apr 2007 17:19:31 +0100 537403 http://www.medworm.com/index.php?rid=537404&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15785%2F MONTVALE, N.J., April 5 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that it has completed enrollment in its Phase 2a trial of MEM 1003 in Alzheimer's disease. The Company expects to report top-line results for this trial in the fourth quarter of 2007. "Completion of enrollment in... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=537404 Wed, 11 Apr 2007 17:14:43 +0100 537404 http://www.medworm.com/index.php?rid=522838&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15495%2F MARQUETTE, Mich., April 3 /PRNewswire-USNewswire/ -- For the third year in a row, thousands of Lutherans will turn in hazardous waste during the annual Earth Keeper Clean Sweep on Earth Day, April 22, at collection sites across northern Michigan. This year the target is pharmaceuticals. Members of the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522838 Thu, 05 Apr 2007 20:05:54 +0100 522838 http://www.medworm.com/index.php?rid=522839&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15494%2F SAN FRANCISCO, April 3 /PRNewswire-FirstCall/ -- Osteologix Inc. (BULLETIN BOARD: OLGX) announced today that it has appointed Philip J. Young as President and Chief Executive Officer, effective May 1, 2007. Mr. Young most recently was Chief Business Officer, Executive Vice President of Insmed, Inc. Previously he has served as an... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522839 Thu, 05 Apr 2007 20:02:19 +0100 522839 http://www.medworm.com/index.php?rid=522840&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15493%2F COLLEGEVILLE, Pa., April 3 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE) , provides comment on a re- analysis of pooled data from both hormone therapy arms of the Women's Health Initiative (WHI) Study published today in the Journal of the American Medical Association. The pooled analysis showed no... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522840 Thu, 05 Apr 2007 20:01:36 +0100 522840 http://www.medworm.com/index.php?rid=522841&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15492%2F ELMIRA, N.Y., April 3 /PRNewswire-FirstCall/ -- Hardinge Inc. (NASDAQ:HDNG) , a leading global provider of advanced material-cutting solutions, today announced that it commenced an underwritten public offering of 1,650,000 shares of common stock from its existing shelf registration statement. The underwriters have been granted an over-allotment option to purchase an... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522841 Thu, 05 Apr 2007 20:00:52 +0100 522841 http://www.medworm.com/index.php?rid=522843&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15491%2F SUNNYVALE, Calif., April 3 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (NASDAQ:PCYC) today announced that it will hold a conference call on Wednesday, April 4, 2007, at 9:00 a.m. EST (6:00 a.m. PST) to discuss company news. To participate in the conference call, please dial 800-497-0451 for domestic callers and 706-758-3306... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522843 Thu, 05 Apr 2007 20:00:01 +0100 522843 http://www.medworm.com/index.php?rid=522845&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15490%2F WALTHAM, Mass., April 3 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE:TMO) , the world leader in serving science, today announced that it has completed the sale of its Genevac business, a manufacturer of vacuum concentrators, to private equity firm Riverlake Equity Partners, LP. Riverlake intends to eventually merge Genevac into... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522845 Thu, 05 Apr 2007 19:59:32 +0100 522845 http://www.medworm.com/index.php?rid=522847&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15489%2F WASHINGTON, April 3 /PRNewswire-USNewswire/ -- With a survey of group practices finding physicians face cultural and infrastructural barriers to adoption of electronic-prescribing technology -- including uncertainty over state regulation in some markets -- the Pharmaceutical Care Management Association (PCMA) today reiterated its call for a national, uniform electronic prescribing (e-prescribing)... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522847 Thu, 05 Apr 2007 19:58:49 +0100 522847 http://www.medworm.com/index.php?rid=522849&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15488%2F ALLENTOWN, Pa., April 3 /PRNewswire/ -- Cegedim North America announced today that Centrix Pharmaceutical of Birmingham, Alabama, has agreed to license and deploy the Target SFA customer relationship management suite for its U.S. sales force. Centrix will use both the Windows Mobile(TM) and web versions of Target Mobile to automate... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522849 Thu, 05 Apr 2007 19:58:15 +0100 522849 http://www.medworm.com/index.php?rid=522850&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15487%2F VANCOUVER, April 3 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI) (NASDAQ:TSX:) (NASDAQ:ANP) , a global specialty pharmaceutical and medical device company, along with its corporate partner, Boston Scientific Corporation (NYSE:BSX) , announced today that Boston Scientific has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to market... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522850 Thu, 05 Apr 2007 19:57:39 +0100 522850 http://www.medworm.com/index.php?rid=522851&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15486%2F MINNEAPOLIS, April 3 /PRNewswire/ -- Soligie, a market leader providing integrated printed electronic solutions, announced today the scheduled opening of their new state of the art printed electronics manufacturing facility. Soligie continues to expand its capacity to meet the growing demand for integrated printed electronic solutions. The new... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522851 Thu, 05 Apr 2007 19:56:57 +0100 522851 http://www.medworm.com/index.php?rid=522852&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15485%2F Group Wages Nationwide Campaign to Help Lower Medicare Drug Prices WASHINGTON, April 3 /PRNewswire-USNewswire/ -- With the aid of its 38 million members, AARP is calling on the U.S. Senate to stand with the overwhelming majority of Americans and vote to give Medicare the power to negotiate for... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522852 Thu, 05 Apr 2007 19:56:28 +0100 522852 http://www.medworm.com/index.php?rid=522853&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15484%2F CHICAGO, April 3 /PRNewswire/ -- closerlook, an innovative communication and relationship marketing company, Internet pioneer, and successful survivor of the early 21st century "tech wreck" celebrates 20 years in business this April 6, 2007. The company has developed unique technology-driven marketing solutions for leading Fortune 500 companies in a host... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522853 Thu, 05 Apr 2007 19:55:07 +0100 522853 http://www.medworm.com/index.php?rid=522855&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15482%2F WILMINGTON, N.C., April 3 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) will release its first quarter 2007 financial results on Tuesday, April 17, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com/, FirstCall and PR Newswire. On Wednesday, April 18,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522855 Thu, 05 Apr 2007 19:53:11 +0100 522855 http://www.medworm.com/index.php?rid=522856&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15481%2F INDIANAPOLIS, April 3 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE:LLY) today announced that it has completed its acquisition of Hypnion, Inc., a privately held neuroscience drug discovery company focused on sleep disorder research. The deal, valued at a total purchase price of $315 million, bolsters Lilly's pipeline with... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522856 Thu, 05 Apr 2007 19:52:34 +0100 522856 http://www.medworm.com/index.php?rid=522857&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15480%2F 2006 Revenues Increase 106%; Operating Loss Decreases 29% IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- Assured Pharmacy, Inc. (BULLETIN BOARD: APHY) today announced financial results for the Company's twelve months ended December 31, 2006. Revenue for 2006 increased 106%, to $7.9 million, from $3.8 million in 2005, with the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522857 Thu, 05 Apr 2007 19:51:34 +0100 522857 http://www.medworm.com/index.php?rid=522858&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15479%2F CAMBRIDGE, Mass., April 3 /PRNewswire/ -- Archemix Corp. announced today that Robert B. Stein, M.D., Ph.D., has been appointed to the company's Board of Directors. Dr. Stein brings to Archemix over 25 years of experience in research and development and business roles with pharmaceutical and biotechnology companies. From... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522858 Thu, 05 Apr 2007 19:51:07 +0100 522858 http://www.medworm.com/index.php?rid=522859&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15478%2F Avastin, Avemar, Boost Conventional Treatment Efficacy, Survival BLAUVELT, New York, April 3 /PRNewswire/ -- People diagnosed with advanced colorectal cancer that has spread to distant organs, such as White House spokesman Tony Snow, are much more likely to survive today than even just a few years ago, due... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522859 Thu, 05 Apr 2007 19:50:33 +0100 522859 http://www.medworm.com/index.php?rid=522860&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15477%2F BEIJING, April 3 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (BULLETIN BOARD: CHBP) , a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, today announced its financial results for the year ended December 31, 2006. Revenues for the year ended December... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522860 Thu, 05 Apr 2007 19:49:50 +0100 522860 http://www.medworm.com/index.php?rid=522861&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15476%2F RESEARCH TRIANGLE PARK, N.C., April 3 /PRNewswire/ -- A new study released by Cutting Edge Information found that many pharmaceutical CRM initiatives suffer from the lack of a firm definition. The report, available at http://pharmaindustrycrm.com/, focuses on the inner-workings and best practices of CRM initiatives at top pharmaceutical... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522861 Thu, 05 Apr 2007 19:36:21 +0100 522861 http://www.medworm.com/index.php?rid=522862&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15475%2F Benefit-Focused Line to Answer Needs of Vital, Active Boomers MORRISTOWN, N.J., April 3 /PRNewswire/ -- Bayer HealthCare announces the introduction of Bayer Nutritional Science(TM), a new line of nutritional supplements that unites science and nutrition to help active Baby Boomers maximize their vitality. The Bayer Nutritional Science(TM) line... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522862 Thu, 05 Apr 2007 19:34:50 +0100 522862 http://www.medworm.com/index.php?rid=522864&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15474%2F InView Delivers a Dashboard of Key Performance Indicators, Dynamic Graphs, and Custom Metrics to Drive Sales Planning and Reporting WEST TRENTON, N.J., April 3 /PRNewswire/ -- Archi-Tech Systems, a leader in pharmaceutical data analysis and reporting solutions, today announced the launch of InView, an interactive reporting portal offering... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522864 Thu, 05 Apr 2007 19:34:17 +0100 522864 http://www.medworm.com/index.php?rid=522865&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15473%2F - Net Income Up 89% Excluding Non-recurring Item - HANGZHOU, China, April 3 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (BULLETIN BOARD: AIDA) , one of mainland China's leading pharmaceutical companies, today announced its financial results for the fiscal year ended December 31, 2006. Excluding a non-recurring, non-cash expense of... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522865 Thu, 05 Apr 2007 19:33:40 +0100 522865 http://www.medworm.com/index.php?rid=522866&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15472%2F REDWOOD CITY, Calif., April 3 /PRNewswire/ -- Codexis, Inc., a private biotechnology company, today announced expansion of its senior management team with the addition of two new positions. Joseph Sarret, M.D., J.D. has been named Vice President, Corporate Development and Douglas Sheehy, J.D. has been appointed Vice President, General Counsel... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522866 Thu, 05 Apr 2007 19:33:00 +0100 522866 http://www.medworm.com/index.php?rid=522867&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15471%2F The 42nd Annual Meeting of the European Association for the Study of the Liver PRINCETON, N.J., April 3 /PRNewswire/ -- Pharmasset announced today that presentations of preclinical studies of Clevudine for the treatment of hepatitis B (HBV) and PSI-6130, the parent molecule of R7128, for the treatment of... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522867 Thu, 05 Apr 2007 19:32:27 +0100 522867 http://www.medworm.com/index.php?rid=522868&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15470%2F Findings indicate early non-responders unlikely to subsequently respond, have substantially more treatment costs, and may benefit from earlier change in treatment strategy COLORADO SPRINGS, Colo., April 3 /PRNewswire-FirstCall/ -- New data presented at the 2007 International Congress on Schizophrenia Research (ICOSR) suggest that antipsychotic drug response be assessed... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522868 Thu, 05 Apr 2007 19:31:49 +0100 522868 http://www.medworm.com/index.php?rid=522869&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15469%2F VANCOUVER, April 3 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI) (NASDAQ:TSX:) (NASDAQ:ANP) , a global specialty pharmaceutical and medical device company, today announced the appointment of Chris Dennis as Senior Vice President, Sales and Marketing. Mr. Dennis brings to Angiotech a broad background in marketing, sales and general management... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522869 Thu, 05 Apr 2007 19:31:16 +0100 522869 http://www.medworm.com/index.php?rid=522870&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15468%2F Only GPO to Offer These Contracts in the Marketplace - SOUTH SAN FRANCISCO, Calif., April 3 /PRNewswire/ -- Onmark, a national group purchasing organization (GPO) for community-based practices and an OTN company, today announced that it has signed new contracts with Pfizer for Camptosar(R) (irinotecan) and with Berlex... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522870 Thu, 05 Apr 2007 19:30:34 +0100 522870 http://www.medworm.com/index.php?rid=522871&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15467%2F SAN DIEGO, April 3 /PRNewswire/ -- MediVas, LLC, a developer of novel drug delivery platforms, today announced the achievement of a milestone relating to its previously disclosed agreement with Merck & Co., Inc. The milestone was specifically connected to one of the several orally available biologics that are the focus... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522871 Thu, 05 Apr 2007 19:29:59 +0100 522871 http://www.medworm.com/index.php?rid=522872&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15466%2F MADISON, N.J., April 3 /PRNewswire-FirstCall/ -- Wyeth (NYSE:WYE) today announced the purchase of the final 20 percent stake of Wyeth K.K. (WKK), from Takeda Pharmaceuticals Company Limited (Takeda), bringing Wyeth's ownership interest in WKK to 100 percent. Wyeth entered into an Equity Transfer Agreement with Takeda in May 2003. Financial... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522872 Thu, 05 Apr 2007 19:29:04 +0100 522872 http://www.medworm.com/index.php?rid=522873&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15465%2F Merck Becomes First Subscriber to Codex(TM) Biocatalyst Panels, Next-Generation Technology Driving Early Stage Adoption Of Custom Biocatalysts by Pharma Manufacturers REDWOOD CITY, Calif., April 3 /PRNewswire/ -- Codexis, Inc., a private biotechnology company, today announced a significant technology collaboration with Merck & Co., Inc. under which Merck will... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522873 Thu, 05 Apr 2007 19:28:25 +0100 522873 http://www.medworm.com/index.php?rid=522874&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15464%2F RADFORD, Va., April 3 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) today announced that, in connection with its previously disclosed pending acquisition by Shire plc pursuant to a "first-step" cash tender offer for all outstanding New River shares at $64.00 per share followed by a "second-step" cash merger at the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522874 Thu, 05 Apr 2007 19:27:43 +0100 522874 http://www.medworm.com/index.php?rid=522875&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15463%2F DUBLIN, Calif., April 3 /PRNewswire-FirstCall/ -- SuperGen Inc. (NASDAQ:SUPG) today announced that it closed on the sale of the remaining worldwide rights for Nipent(R) (pentostatin for injection) to Mayne Pharma, which was acquired in February 2007 by Hospira, for a total consideration of US$8 million. SuperGen received an initial up-front... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522875 Thu, 05 Apr 2007 19:26:54 +0100 522875 http://www.medworm.com/index.php?rid=522876&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15462%2F PALO ALTO, Calif., April 3 /PRNewswire/ -- Frost & Sullivan has presented Atlanta-based Altea Therapeutics with the 2007 Frost & Sullivan Technology Innovation Award in the field of transdermal drug delivery for its development of the PassPort(TM) System, a new breakthrough technology that enables painless delivery through the skin of... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522876 Thu, 05 Apr 2007 19:26:16 +0100 522876 http://www.medworm.com/index.php?rid=522877&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15461%2F SEBASTIAN, Fla., April 3 /PRNewswire/ -- PHM International, Inc. a worldwide healthcare consultancy is pleased to announce the launch of PHM Emerging Markets Healthcare Monitor -- the only professional trade publication devoted exclusively to key healthcare/life sciences sector developments in transactions and regulatory change in emerging markets/economies. Available... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522877 Thu, 05 Apr 2007 19:25:36 +0100 522877 http://www.medworm.com/index.php?rid=522878&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15460%2F SOPHIA ANTIPOLIS, France, April 3 /PRNewswire/ -- NicOx S.A. (Eurolist: COX) today announced that it has initiated the second pivotal phase 3 trial for naproxcinod in patients with osteoarthritis of the knee (the 302 study). The trial is expected to enroll approximately 1020 patients at around 120 clinical centers in... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522878 Thu, 05 Apr 2007 19:24:52 +0100 522878 http://www.medworm.com/index.php?rid=522879&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15459%2F SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- Alliance (BULLETIN BOARD: ALLP) today announced that it held two teleconferences with the holders of its outstanding Senior Convertible Promissory Notes ("Senior Notes"). The first teleconference took place on March 30, 2007. This teleconference was repeated on April 2, 2007. In connection... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522879 Thu, 05 Apr 2007 19:16:25 +0100 522879 http://www.medworm.com/index.php?rid=522880&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15458%2F CARLSBAD, Calif., April 2 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. ("Ardea" or the "Company") (Pink Sheets: ARDC) today reported financial results for the fourth quarter and twelve months ended December 31, 2006. Ardea reported a net loss applicable to common stockholders of $476,000, or $0.05 per basic and diluted... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522880 Thu, 05 Apr 2007 19:07:21 +0100 522880 http://www.medworm.com/index.php?rid=522881&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15457%2F VANCOUVER, April 2 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG; BBSE: DRP) today announced the results for its fiscal year ended December 31, 2006. As previously disclosed, Dragon sold a part of its formulation business effective July 1, 2006, therefore the financial results of 2005 were reclassified... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522881 Thu, 05 Apr 2007 19:06:32 +0100 522881 http://www.medworm.com/index.php?rid=522882&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15456%2F - Q4 2006 net revenues grew 36.0%, as compared to Q4 2005, to US$4.5 million - Q4 2006 operating income up 148.1%, as compared to Q4 2005, to US$1.1 million - 2006 fiscal year net revenues increased 25.3% year-over-year to US$16.4 million - 2006... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522882 Thu, 05 Apr 2007 19:05:57 +0100 522882 http://www.medworm.com/index.php?rid=522883&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15455%2F REDWOOD CITY, Calif., April 2 /PRNewswire-FirstCall/ -- Genelabs Technologies, Inc. (NASDAQ:GNLB) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase III clinical trial of Prestara(TM) (prasterone) for treatment of systemic lupus erythematosus (lupus). (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522883 Thu, 05 Apr 2007 19:04:50 +0100 522883 http://www.medworm.com/index.php?rid=522884&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15454%2F CAMBRIDGE, Mass., April 2 /PRNewswire-FirstCall/ -- Advanced Magnetics, Inc. (NASDAQ:AMAG) today announced that Jerome Goldstein, the Executive Chairman of the Board of Directors and founder of the company, will retire as an officer and director of the company effective May 1, 2007. The company's Board of Directors voted to confer... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522884 Thu, 05 Apr 2007 19:04:13 +0100 522884 http://www.medworm.com/index.php?rid=522885&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15453%2F FORT LEE, N.J., April 2 /PRNewswire/ -- DAVA Pharmaceuticals, Inc. announced today that under the terms of an agreement signed on March 30, 2007, between IMPAX Laboratories, Inc. and Purdue Pharma L.P. and certain of its affiliates to settle patent infringement litigation pertaining to IMPAX's generic versions of Purdue's Oxycontin(R)... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522885 Thu, 05 Apr 2007 19:03:29 +0100 522885 http://www.medworm.com/index.php?rid=522886&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15452%2F Largest national study ever conducted among current AND potential users of retail clinics discovers substantial interest in retail clinics to receive basic care, as well as more complex care treatment; significant implications for physicians, hospitals, insurers, pharmacies and pharmaceutical companies LIVONIA, Mich., April 2 /PRNewswire/ -- On Monday,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522886 Thu, 05 Apr 2007 19:02:55 +0100 522886 http://www.medworm.com/index.php?rid=522887&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15451%2F - DelliSanti to Head Worldwide Sales, Marketing and Services Efforts - HOPKINTON, Mass., April 2 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (NASDAQ:CALP) today announced that John DelliSanti has joined the company as executive vice president and chief commercial officer. In this position, Mr. DelliSanti will lead Caliper's Commercial... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522887 Thu, 05 Apr 2007 19:02:17 +0100 522887 http://www.medworm.com/index.php?rid=522888&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15450%2F ARLINGTON, Va., April 2 /PRNewswire-USNewswire/ -- According to the findings of a recent study, Invitrogen has the most visible sales force among life scientists. The study also reports that GE Healthcare has the greatest percent of "promoters" due to the influence of their sales force, indicating that a larger proportion... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522888 Thu, 05 Apr 2007 19:01:37 +0100 522888 http://www.medworm.com/index.php?rid=522889&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15449%2F SAN DIEGO, California, April 2/PRNewswire-FirstCall/ -- Cardiff, a division of Autonomy Corporation plc (LSE: AU. or AU.L) and leading provider of intelligent document solutions, today announced that Pfizer, the world's largest research-based pharmaceutical company, has signed an agreement to deploy Cardiff TeleForm v10.1 within the company for data capture. Cardiff's... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522889 Thu, 05 Apr 2007 19:01:08 +0100 522889 http://www.medworm.com/index.php?rid=522890&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15448%2F SAN FRANCISCO, April 2 /PRNewswire/ -- It was a roller coaster ride for the capital markets in the first quarter of the year although the bellweather Dow Jones Industrial Average and NASDAQ indices finished almost where they had started. The Dow was up a fraction (0.69%) for March but down... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522890 Thu, 05 Apr 2007 19:00:33 +0100 522890 http://www.medworm.com/index.php?rid=522891&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15447%2F Information Technology Companies Drive Exit Activity NEW YORK, April 2 /PRNewswire-FirstCall/ -- Seventeen venture-backed companies raised $2.09 billion through initial public offerings (IPOs) on US exchanges in the first quarter of 2007, according to the Exit Poll report by Thomson Financial and the National Venture Capital Association (NVCA).... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522891 Thu, 05 Apr 2007 18:59:52 +0100 522891 http://www.medworm.com/index.php?rid=522892&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15446%2F Customers Nationwide Already Benefiting from AG Mednet Solution BOSTON, April 2 /PRNewswire/ -- In the ever-changing healthcare world, hospitals and diagnostic imaging centers, radiologists and clinical trial settings face a number of critical challenges regarding the delivery of medical images. To address these challenges, AG Mednet today launched... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522892 Thu, 05 Apr 2007 18:59:19 +0100 522892 http://www.medworm.com/index.php?rid=522893&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15445%2F Presentation to Include the Recently Released Positive Results from Preliminary Clinical Trials of the Company's AppyScore(TM) and AppyScreen(TM), Being Developed as the World's First and Only Blood-Based Tests for Human Appendicitis CASTLE ROCK, Colo., April 2 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (BULLETIN BOARD: APNB) an emerging bio-pharmaceutical company... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522893 Thu, 05 Apr 2007 18:58:37 +0100 522893 http://www.medworm.com/index.php?rid=522894&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15444%2F Good News: Percentage of Working Age People with Diabetes, Hospital and Professional Charges Lower Than Both PA and National Averages Bad News: Percentage of Seniors with Diabetes Significantly Higher Than Both the PA & National Averages PITTSBURGH, April 2 /PRNewswire-FirstCall/ -- The Pittsburgh Business Group on... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522894 Thu, 05 Apr 2007 18:58:09 +0100 522894 http://www.medworm.com/index.php?rid=522895&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15443%2F KCP unitholders to receive C$10.00 per unit TORONTO and NEW YORK, April 2 /PRNewswire-FirstCall/ -- KCP Income Fund (the "Fund" or "KCP") (TSX: KCP.UN) and Caxton-Iseman Capital, Inc. today announced that KCP has entered into a definitive agreement with an acquisition vehicle organized by Caxton-Iseman providing for the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522895 Thu, 05 Apr 2007 18:57:06 +0100 522895 http://www.medworm.com/index.php?rid=522896&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15442%2F Lack of Reimbursement for Obesity Drugs Will Continue to Inhibit Consumer Uptake, According to a New Report from Decision Resources WALTHAM, Mass., April 2 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the prevalence... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522896 Thu, 05 Apr 2007 18:56:16 +0100 522896 http://www.medworm.com/index.php?rid=522897&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15441%2F CAMBRIDGE, Mass., April 2 /PRNewswire/ -- Radius today announced that it has raised $57.5 million in its second institutional financing. Existing investor MPM Capital and new investor The Wellcome Trust co-led the round, which brings the total amount raised since the company's inception in 2003 to $81.5 million. (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522897 Thu, 05 Apr 2007 18:55:44 +0100 522897 http://www.medworm.com/index.php?rid=522898&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15440%2F NEW YORK, April 2 /PRNewswire-FirstCall/ -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced it completed a private placement of common stock and warrants with certain institutional and other accredited investors. The company expects to use the net proceeds for general corporate purposes. The company sold approximately 10.2 million shares... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522898 Thu, 05 Apr 2007 18:55:04 +0100 522898 http://www.medworm.com/index.php?rid=522899&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15439%2F IMPAX acknowledges validity, enforceability and infringement of Purdue Pharma's OxyContin patents STAMFORD, Conn., April 2 /PRNewswire/ -- Purdue Pharma L.P. of Stamford, Connecticut and IMPAX Laboratories, Inc. of Hayward, California have agreed to end their lawsuit concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled-release) Tablets. Under... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522899 Thu, 05 Apr 2007 18:54:31 +0100 522899 http://www.medworm.com/index.php?rid=522900&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15438%2F Latest in Grid Technology and the Full Range of Oracle Products Will Sharpen Tourtellote Customers' Competitive Edge. WAYLAND, Mass., April 2 /PRNewswire/ -- Tourtellotte Solutions, a global leader in off-the-shelf and custom supply chain software for the retail, consumer goods, and pharmaceutical industries, today announced that it has... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522900 Thu, 05 Apr 2007 18:53:52 +0100 522900 http://www.medworm.com/index.php?rid=522901&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15437%2F MALVERN, Pa., April 2 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) today announced that Mr. Armando Anido, Chief Executive Officer and President, and Mr. Jim Fickenscher, Chief Financial Officer, will participate in the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference to be held April 11 through April 12, 2007... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522901 Thu, 05 Apr 2007 18:53:12 +0100 522901 http://www.medworm.com/index.php?rid=522902&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15436%2F Partnership Brings Predicted LogP and Related Property Values to More Than 5 Million Chemical Structures Online DEL MAR, Calif. and TORONTO, April 2 /PRNewswire/ -- eMolecules, Inc., the provider of the world's largest online chemistry database, and Advanced Chemistry Development, Inc. (ACD/Labs), today announced a collaboration that will... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522902 Thu, 05 Apr 2007 18:52:43 +0100 522902 http://www.medworm.com/index.php?rid=522903&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15435%2F Patent-pending System Streamlines Tracking of Onboard Expirable Medications for Commercial Shipping Vessels TEMPE, Ariz., April 2 /PRNewswire/ -- MAS, a service of MedAire -- the global provider of remote medical expertise, education, and equipment (ASX Code: MDE) -- has launched the patent-pending Medical Inventory Control System(TM) designed to... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522903 Thu, 05 Apr 2007 18:52:13 +0100 522903 http://www.medworm.com/index.php?rid=522904&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15434%2F Manz Bolsters Capabilities of Industry-leading Laser Processing Tools by Integrating Synova's Laser MicroJet(R) Technology into its Manufacturing Systems REUTLINGEN, Germany and LAUSANNE, Switzerland, April 2 /PRNewswire/ -- Manz Automation AG, a leading systems and components supplier, and Synova SA, the world pioneer of water jet-guided laser technology, today... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522904 Thu, 05 Apr 2007 18:51:43 +0100 522904 http://www.medworm.com/index.php?rid=522905&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15433%2F Relationship Brings New Technology Best Practices in Equipment Protection to the Security Industry INDIANAPOLIS, April 2 /PRNewswire/ -- Integral Technologies, Inc. today announced the formation of a strategic partnership with American Power Conversion (APC-MGE). This relationship strengthens Integral's position as an IT-centric organization that delivers technology best practices... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522905 Thu, 05 Apr 2007 18:50:54 +0100 522905 http://www.medworm.com/index.php?rid=522906&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15432%2F BUENA, N.J., April 2 /PRNewswire/ -- Comar, Inc. today announced that on Friday, March 30, 2007, it has successfully completed the sale of its glass division to Gerresheimer's Kimble Glass, Inc. operation. Kimble Glass, Inc. is a leading manufacturer and marketer of tubular glass products throughout North America. Comar will... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522906 Thu, 05 Apr 2007 18:50:18 +0100 522906 http://www.medworm.com/index.php?rid=522907&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15431%2F SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced that it has promoted Karen A. Sztraicher to the position of Vice President, Finance and Treasurer, effective April 2, 2007. Ms. Sztraicher has served as Vice President - Chief Accounting Officer of the company since March 2005,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522907 Thu, 05 Apr 2007 18:49:41 +0100 522907 http://www.medworm.com/index.php?rid=522908&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15430%2F MUNICH, Germany, April 2/PRNewswire/ -- With the completion of its worldwide integration process on April 1st , 2007, DAIICHI SANKYO has set the course for further global growth. The pharmaceutical concern believes that its future lies in pursuing its ambitious plan of becoming a 'global pharma innovator'. In Europe, strengthened... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522908 Thu, 05 Apr 2007 18:49:01 +0100 522908 http://www.medworm.com/index.php?rid=522909&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15429%2F Financing Round Led by Vaekstfonden Life Science Ventures COPENHAGEN, Denmark, April 2/PRNewswire/ -- Egalet a/s, a specialty pharma company focused on the development of oral controlled-release products, today announced that it has successfully raised US$19.27 million (DKK107.7 million) in a Series B financing led by internationally renowned Danish... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522909 Thu, 05 Apr 2007 18:47:47 +0100 522909 http://www.medworm.com/index.php?rid=522910&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15428%2F Winners Include: Acme, Alley-Cassetty, Boral, Glen-Gery, Summit*Lakewood, Lawrenceville & Nash Brick Companies, as Well as Belden Brick Sales & Service RESTON, Va., April 1 /PRNewswire/ -- Outstanding programs in environmental stewardship, and employee health and safety were honored Saturday night by the Brick Industry Association (BIA) at its... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522910 Thu, 05 Apr 2007 18:45:48 +0100 522910 http://www.medworm.com/index.php?rid=522911&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15427%2F Helix today announced positive results from its phase II clinical study of its Topical Interferon Alpha-2b in women with human papilloma virus (HPV) induced low-grade cervical lesions. The study showed a clinically efficacious... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522911 Thu, 05 Apr 2007 18:45:13 +0100 522911 http://www.medworm.com/index.php?rid=522912&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15426%2F VANCOUVER, March 30 /PRNewswire-FirstCall/ -- Inex Pharmaceuticals Corporation ("INEX"; TSX: IEX) announced today that it has extended the closing of the spin-out of Tekmira Pharmaceuticals Corporation ("Tekmira") from March 31, 2007 to April 30, 2007 at the request of the group that will be investing ("Investor Group") approximately $5.6 million... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522912 Thu, 05 Apr 2007 18:44:43 +0100 522912 http://www.medworm.com/index.php?rid=522913&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15425%2F PALO ALTO, Calif., March 30 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) today announced that it has filed a universal shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, will allow the Company to sell, from time to time, up to $150 million... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522913 Thu, 05 Apr 2007 18:42:33 +0100 522913 http://www.medworm.com/index.php?rid=522914&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15424%2F IRVINE, Calif., March 30 /PRNewswire/ -- Superior Controls, Inc., Plaistow, NH, and Finesse Solutions, LLC, Santa Clara, CA, have signed a licensing agreement for the TruBio(TM) OS -- the first digitally enabled, fully configurable "Open" Bioprocess Control System. This agreement will enable Superior Controls Inc. to deliver TruBio(TM) solutions to... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522914 Thu, 05 Apr 2007 18:42:01 +0100 522914 http://www.medworm.com/index.php?rid=522915&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15423%2F FRAZER, Pa., March 30 /PRNewswire-FirstCall/ -- Cephalon, Inc. (NASDAQ:CEPH) today announced that it has received an approvable letter, together with draft labeling, from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) for NUVIGIL(TM) (armodafinil) Tablets [C-IV] for the treatment of excessive sleepiness associated with narcolepsy,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522915 Thu, 05 Apr 2007 18:41:34 +0100 522915 http://www.medworm.com/index.php?rid=522916&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15422%2F FARMINGTON, Conn., March 30 /PRNewswire-FirstCall/ -- Familymeds Group, Inc. (BULLETIN BOARD: FMRX) , a specialty pharmacy and medical specialty product provider, today announced that during the special meeting of shareholders held today, Friday March 30th in Farmington CT, the shareholders voted for the approval of each of the proposals as... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522916 Thu, 05 Apr 2007 18:40:59 +0100 522916 http://www.medworm.com/index.php?rid=522917&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15421%2F RESEARCH TRIANGLE PARK, N.C., March 30 /PRNewswire/ -- A study by pharmaceutical business intelligence firm, Cutting Edge Information, found that patient adherence and disease management programs implemented close to a drug's launch brought greatest value to companies (http://www.pharmapatientadherence.com/). Interviewees for this study reiterated the importance of beginning patient... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522917 Thu, 05 Apr 2007 18:40:26 +0100 522917 http://www.medworm.com/index.php?rid=522918&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15420%2F TUSTIN, Calif., March 30 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) , a clinical stage biopharmaceutical company developing targeted therapeutics for the treatment of cancer and hepatitis C virus (HCV) infection, today commented on a cross-complaint filed by Cancer Therapeutics Laboratories Inc. (CTL) and discussed in a press release issued yesterday... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522918 Thu, 05 Apr 2007 18:39:50 +0100 522918 http://www.medworm.com/index.php?rid=522919&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15419%2F SAN FRANCISCO, March 30 /PRNewswire/ -- Epiphany Biosciences, Inc. announced six appointments to its board of directors. The directors include Charles Sanders, MD, former Chairman and CEO of Glaxo, Inc.; Clyde T. Turner, Chairman and CEO of Global Trust Ventures, LLC; John Quelch, DBA, MBA, MS, Senior Associate Dean and... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522919 Thu, 05 Apr 2007 18:39:15 +0100 522919 http://www.medworm.com/index.php?rid=522920&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15418%2F Scientists Working in Clinical, Pre-Clinical, and Formulation Areas Leverage a New Offering from Pharsight MOUNTAIN VIEW, Calif., March 30 /PRNewswire-FirstCall/ -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, and Servier Laboratories Ltd, the British subsidiary of... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522920 Thu, 05 Apr 2007 18:38:31 +0100 522920 http://www.medworm.com/index.php?rid=522921&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15417%2F COLLEGEVILLE, Pa., March 30 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE) , Solvay Pharmaceuticals, Inc. and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week. Safety analyses suggest bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, was associated with a... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522921 Thu, 05 Apr 2007 18:37:45 +0100 522921 http://www.medworm.com/index.php?rid=522922&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15416%2F Company Promotes Dan Weiner to Chief Technology Officer, Dana C. Cambra Joins as Vice President of R&D MOUNTAIN VIEW, Calif., April 5 /PRNewswire-FirstCall/ -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, strengthened its management team today... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522922 Thu, 05 Apr 2007 17:28:55 +0100 522922 http://www.medworm.com/index.php?rid=522923&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15415%2F SAN DIEGO, April 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc., (AMEX:ANX) , a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, today announced that it has entered into an agreement with Hyaluron Contract Manufacturing to manufacture ANX-514 (docetaxel emulsion) for... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522923 Thu, 05 Apr 2007 17:28:28 +0100 522923 http://www.medworm.com/index.php?rid=522924&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15414%2F ROSEVILLE, Calif., April 5 /PRNewswire/ -- CoolTouch Inc., a pioneering manufacturer of medical lasers announced today that the United States Patent & Trademark Office has allowed the patent "Treatment of Cellulite with Mid-Infrared Radiation" to CoolTouch Inc. The inventors of the patent are David R. Hennings, CoolTouch CEO and Mitchel... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522924 Thu, 05 Apr 2007 17:28:00 +0100 522924 http://www.medworm.com/index.php?rid=522925&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15413%2F COLORADO SPRINGS, Colo., April 5 /PRNewswire-FirstCall/ -- Spectranetics Corporation (NASDAQ:SPNC) announced today that it has hired Shahriar (Shar) Matin as Managing Director of Spectranetics, BV. Mr. Matin will have responsibility for all of the Company's operations in Europe, Russia and the Middle East, and report directly to Spectranetics' Chief Executive... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522925 Thu, 05 Apr 2007 17:26:50 +0100 522925 http://www.medworm.com/index.php?rid=522926&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15412%2F Findings Show Survival Improvement with Lower Doses of Dexamethasone, the Steroid Commonly Used with REVLIMID(R) and other Drugs in Newly Diagnosed Myeloma - - Findings Challenge Traditional Assumption that More-Is-Better when Treating Cancer - NORTH HOLLYWOOD, Calif., April 4 /PRNewswire/ -- The International Myeloma Foundation (IMF)... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522926 Thu, 05 Apr 2007 17:26:18 +0100 522926 http://www.medworm.com/index.php?rid=522927&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15411%2F NORCROSS, Ga., April 4 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD) , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal third quarter ended February 28, 2007. Revenue for the fiscal third quarter was a record $57.1 million, up... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522927 Thu, 05 Apr 2007 17:25:43 +0100 522927 http://www.medworm.com/index.php?rid=522928&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F15410%2F WASHINGTON, April 4 /PRNewswire-USNewswire/ -- Medical device industry leaders, lawmakers, and government officials will gather for the 2007 Annual Meeting of the Medical Device Manufacturers Association (MDMA) on May 17th and 18th at the Grand Hyatt hotel in Washington, D.C. (Logo: http://www.newscom.com/cgi-bin/prnh/20070227/DCTU110LOGO ) Meeting... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=522928 Thu, 05 Apr 2007 17:24:53 +0100 522928 http://www.medworm.com/index.php?rid=510387&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14844%2F MIDDLETOWN - Pennsylvania Lottery officials will present a ceremonial check at 1 p.m. on Tuesday, Feb. 27, to a Hickory, Washington County, woman who won the $3,000-a-month-for-life top prize in the Dec. 4, 2006, Lucky For Life Lotto drawing. The event will take place at Kehn's Korner Market, 21 Main... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510387 Fri, 30 Mar 2007 16:32:41 +0100 510387 http://www.medworm.com/index.php?rid=510388&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14843%2F FRANKLIN LAKES, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Timothy C. Wentworth, president and CEO of Accredo Health Group, Inc., the specialty pharmacy subsidiary of Medco Health Solutions, Inc. (NYSE:MHS) , is scheduled to address the Raymond James 28th Annual Institutional Investors Conference in Orlando, Fla. on Monday, March 5, 2007. (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510388 Fri, 30 Mar 2007 16:31:39 +0100 510388 http://www.medworm.com/index.php?rid=510389&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14842%2F Gilead/BMS's Atripla Is Setting the Clinical Benchmark for Future Antiretrovirals, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 26 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that HIV specialists desire antiretrovirals... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510389 Fri, 30 Mar 2007 16:30:51 +0100 510389 http://www.medworm.com/index.php?rid=510390&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14841%2F The United Nations Information Center invites you to the launch of the Annual Report of the International Narcotics Control Board on Wednesday, 28 February at 1:00 p.m. at the United Nations Foundation 1800 Massachusetts Ave., NW -- The increasing trend of counterfeit medicines and the danger posed by... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510390 Fri, 30 Mar 2007 16:30:03 +0100 510390 http://www.medworm.com/index.php?rid=510391&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14840%2F International, parallel group, randomized, double-blind study of vandetanib in combination with Alimta(R) (pemetrexed) for advanced non-small cell lung cancer (NSCLC) after failure of first line anti-cancer therapy WILMINGTON, Del., Feb. 26 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the commencement of a new Phase III study of its... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510391 Fri, 30 Mar 2007 16:29:17 +0100 510391 http://www.medworm.com/index.php?rid=510392&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14839%2F PHILADELPHIA, Feb. 26 /PRNewswire/ -- . With new reports showing almost half of Medicare beneficiaries enrolled in prescription drug plans in 2006 were impacted by the Medicare Part D coverage gap known as the "donut hole," Shire is pleased to announce the launch of a new Medicare Part D component... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510392 Fri, 30 Mar 2007 16:28:30 +0100 510392 http://www.medworm.com/index.php?rid=510393&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14838%2F CRANBURY, N.J. and BRISTOL, Tenn., Feb. 26 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (AMEX:PTN) and King Pharmaceuticals, Inc. (NYSE:KG) announced that data from Part 2 of a Phase IIa pilot study evaluating the effects of bremelanotide in post-menopausal women diagnosed with female sexual arousal disorder (FSAD) was presented yesterday, February 25,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510393 Fri, 30 Mar 2007 16:21:04 +0100 510393 http://www.medworm.com/index.php?rid=510394&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14837%2F INDIANAPOLIS, February 26/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta(R) (duloxetine HCl) for the treatment of generalised anxiety disorder (GAD), Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim announced today. The approval is based on the results... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510394 Fri, 30 Mar 2007 16:20:03 +0100 510394 http://www.medworm.com/index.php?rid=510395&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14836%2F Data Presented at AAAAI Annual Meeting -- SOMERSET, N.J., Feb. 25 /PRNewswire/ -- The prescription antihistamine Astelin(R) (azelastine HCl) Nasal Spray(R) relieved the major symptoms of pollen allergy, including sneezing, runny nose and congestion, within 15 minutes of application compared to placebo and maintained efficacy at all time... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510395 Fri, 30 Mar 2007 16:16:54 +0100 510395 http://www.medworm.com/index.php?rid=510396&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14835%2F WASHINGTON, Feb. 24 /PRNewswire-USNewswire/ -- The following is a radio address by President Bush to the nation: THE PRESIDENT: Good morning. This week, I traveled to a hospital in Chattanooga, Tennessee, where I visited with doctors and health care experts. We discussed an urgent priority for our Nation,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510396 Fri, 30 Mar 2007 16:12:03 +0100 510396 http://www.medworm.com/index.php?rid=510397&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14834%2F Court Again Enjoins Caremark Vote on Acquisition by CVS, This Time for at Least 20 Days Recognizes Caremark Stockholders Have Appraisal Rights ST. LOUIS, Feb. 23 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (NASDAQ:ESRX) today commented on the ruling by the Court of Chancery of the State of... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510397 Fri, 30 Mar 2007 16:11:09 +0100 510397 http://www.medworm.com/index.php?rid=510398&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14833%2F Patient Safety Authority issues risk predictors and guidance to prevent the third most common cause of hospital-acquired kidney failure HARRISBURG, Pa., March 29 /PRNewswire-USNewswire/ -- Performing x-rays using iodine dye places patients with impaired kidney function at increased risk for kidney failure. Known as Contrast-Induced Nephropathy (ne-FROPP-a- thee)... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510398 Fri, 30 Mar 2007 14:02:43 +0100 510398 http://www.medworm.com/index.php?rid=510399&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14832%2F DUBLIN, Ohio, March 29 /PRNewswire-FirstCall/ -- Cardinal Health, Inc. (NYSE:CAH) , a global provider of products and services that improve the safety and productivity of health care, plans to release third-quarter results for its fiscal 2007 on Thursday, Apr. 26, prior to the opening of trading on the New York... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510399 Fri, 30 Mar 2007 14:02:02 +0100 510399 http://www.medworm.com/index.php?rid=510400&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14831%2F AHF Brings HIV/AIDS Disease Management Services to California Medi-Cal Recipients Living with HIV/AIDS. Goals: Increase Patients' Health Outcomes While Reducing State's Costs LOS ANGELES, March 29 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare, prevention and education provider, which operates AIDS treatment clinics in the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510400 Fri, 30 Mar 2007 14:01:14 +0100 510400 http://www.medworm.com/index.php?rid=510401&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14830%2F CHICAGO, and LANHAM, Md., March 29 /PRNewswire-FirstCall/ -- Allscripts (NASDAQ:MDRX) , the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, today announced that Doctors Community Hospital has selected the HealthMatics(R) ED Emergency Department Information System (EDIS) to automate operations and improve access to... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510401 Fri, 30 Mar 2007 14:00:31 +0100 510401 http://www.medworm.com/index.php?rid=510402&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14829%2F London, 28 March/GNN/ -- DEPARTMENT OF HEALTH News Release (2007/0071) issued by The Government News Network on 28 March 2007 PLEASE NOTE EMBARGO Not for publication or broadcast before 0001 hours Wednesday 28 Mar 2007 Computer-based therapy for milder, but more common mental health conditions such... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510402 Fri, 30 Mar 2007 13:53:57 +0100 510402 http://www.medworm.com/index.php?rid=510403&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14828%2F CHELSEA, Mass., March 28 /PRNewswire/ -- HIVConnect.net (www.HIVConnect.net), the latest nonprofit project by former Manhunt general manager, Stephan Adelson, is a place of free dialogue for people with HIV/AIDS, AIDS Services Organizations, Community Based Organizations, AIDS Service Organizations, researchers and others in the community. Launched on March 1st,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510403 Fri, 30 Mar 2007 13:52:50 +0100 510403 http://www.medworm.com/index.php?rid=510404&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14827%2F ALEXANDRIA, Va., March 28 /PRNewswire/ -- Community MTM Services, Inc. (CMTM), a leading developer of clinical solutions that facilitate pharmacist- based medication management and patient care services, today announced the appointment of Mark Carberry as its Chief Operating Officer and Chief Information Officer. Mark will be responsible for... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510404 Fri, 30 Mar 2007 13:52:06 +0100 510404 http://www.medworm.com/index.php?rid=510405&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14826%2F New Generation OTC Laxative Works With the Body to Restore its Natural Rhythm KENILWORTH, N.J., March 28 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today announced that prescription-strength MiraLAX(R) (polyethylene glycol 3350) is now available as an over-the-counter (OTC) treatment for occasional constipation. The innovative formula of MiraLAX works with... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510405 Fri, 30 Mar 2007 13:51:05 +0100 510405 http://www.medworm.com/index.php?rid=510406&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14825%2F Centers for Medicare and Medicaid Services' Rule Proposes to Reimburse Pharmacies on Average 36% Below the Actual Costs for Generic Drugs Dispensed to Medicaid Patients WASHINGTON, March 27 /PRNewswire-USNewswire/ -- Nearly half of the United States Senate, 46 Senators, signed a letter to the Centers for Medicare and... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510406 Fri, 30 Mar 2007 13:38:54 +0100 510406 http://www.medworm.com/index.php?rid=510407&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14824%2F First patient dosed in HZT-501 study that will evaluate reduction in risk for development of ibuprofen-associated ulcers - PALO ALTO, Calif., March 27 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that it has initiated its phase 3 trial program for HZT-501, a "GI-friendly"... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510407 Fri, 30 Mar 2007 13:37:55 +0100 510407 http://www.medworm.com/index.php?rid=510408&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14823%2F Non-profit Buprenorphine Treatment and Opioid Addiction education awareness organization NAABT uses technology to help connect patients to certified physicians treating opioid addiction using buprenorphine. FARMINGTON, Conn., March 27 /PRNewswire-USNewswire/ -- The National Alliance of Advocates for Buprenorphine Treatment's (www.naabt.org) confidential Patient/Physician Matching System helps connect people addicted to... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510408 Fri, 30 Mar 2007 13:37:07 +0100 510408 http://www.medworm.com/index.php?rid=510409&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14822%2F Customer Use of HCLL(TM) Exceeds 10,000 Consecutive Days LENEXA, Kan., March 26 /PRNewswire-FirstCall/ -- Mediware Information Systems (NASDAQ:MEDW) announces that early this month its HCLL(TM) Transfusion Management software system exceeded 10,000 days of productive use in hospitals worldwide, a feat that is indicative of the strong market acceptance... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510409 Fri, 30 Mar 2007 13:30:36 +0100 510409 http://www.medworm.com/index.php?rid=510410&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14821%2F 2007: Kaiser Permanente Northern and Southern California - Member of HMO Lobbying Group that recently went public supporting Assisted Suicide and AB 374 LOS ANGELES, March 26 /PRNewswire-USNewswire/ -- In the wake of the recent support of a managed care lobbying group for assisted suicide, let us be... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510410 Fri, 30 Mar 2007 13:29:29 +0100 510410 http://www.medworm.com/index.php?rid=510411&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14820%2F WASHINGTON, March 26 /PRNewswire/ -- America's Health Insurance Plans (AHIP) is pleased to announce a strategic partnership with Health Literacy Innovations, a software company offering a revolutionary new tool for companies and individuals who are interested in promoting clear health communication and improving printed materials for consumers and patients. (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510411 Fri, 30 Mar 2007 13:28:32 +0100 510411 http://www.medworm.com/index.php?rid=510412&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14819%2F New study results show more patients receiving both Tekturna and Diovan reached target blood pressure goal compared to those taking either agent alone * Tekturna approved in the U.S. as first direct renin inhibitor, works by directly targeting an enzyme which triggers a process that can lead to... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510412 Fri, 30 Mar 2007 13:27:11 +0100 510412 http://www.medworm.com/index.php?rid=510413&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14818%2F NeoFax expedites delivery of neonatal drug dosing and parenteral nutrition information to physicians, nurses and pharmacists to prevent adverse drug events GREENWOOD VILLAGE, Colo., March 26 /PRNewswire/ -- Thomson Healthcare, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and the leading provider of healthcare decision support solutions... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510413 Fri, 30 Mar 2007 13:16:16 +0100 510413 http://www.medworm.com/index.php?rid=510414&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14817%2F Recipients of 'GI Nurse and Associate of the Year Awards' Honored for Commitment to Patient Care CINCINNATI, March 26 /PRNewswire-FirstCall/ -- This week, more than 500 awards will be presented to nurses, associates and nursing teams in the gastroenterology and endoscopy fields around the country. They will be... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510414 Fri, 30 Mar 2007 13:15:00 +0100 510414 http://www.medworm.com/index.php?rid=510415&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14816%2F New medicine will be fixed-dose combination of ezetimibe and atorvastatin KENILWORTH, N.J., March 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today announced that it has entered into an agreement with Merck & Co., Inc. to commence development of an ezetimibe and atorvastatin combination product. "This important new... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510415 Fri, 30 Mar 2007 13:14:08 +0100 510415 http://www.medworm.com/index.php?rid=510416&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14815%2F Initial Analysis Shows Statistically Significant Changes in Agitation Levels With 10 mg AZ-004 PALO ALTO, Calif., March 26 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) today announced positive initial results from its Phase IIa clinical trial of AZ-004 (Staccato(R) loxapine) in schizophrenic patients with acute agitation. The 10 mg... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510416 Fri, 30 Mar 2007 13:12:56 +0100 510416 http://www.medworm.com/index.php?rid=510417&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14814%2F Two-year review of TAXUS Stent safety data presented at ACC NATICK, Mass. and NEW ORLEANS, March 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced two-year results from its ARRIVE 1 registry and the combined one-year results of the ARRIVE 1 and ARRIVE 2 registries, which study the... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510417 Fri, 30 Mar 2007 13:08:56 +0100 510417 http://www.medworm.com/index.php?rid=510418&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14813%2F In the news release, Omnicell (NASDAQ:OMCL) Announces Adjustments to Previously Reported 2006 Financial Results, issued earlier today by Omnicell, Inc. over PR Newswire, we are advised by the company that the fifth paragraph should read "form 10K filed with the SEC today, March 23, 2007" rather than "March 12, 2007"... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510418 Fri, 30 Mar 2007 13:02:49 +0100 510418 http://www.medworm.com/index.php?rid=510419&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14812%2F Simvastatin To Be Made Free To Eligible Anthem Members For Up to Four Months March 23, 2007 - Las Vegas, Nevada - Anthem Blue Cross and Blue Shield today announced the addition of Simvastatin, the generic equivalent of the blockbuster cholesterol fighter Zocor(R), to the list of drugs... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510419 Fri, 30 Mar 2007 13:01:33 +0100 510419 http://www.medworm.com/index.php?rid=510420&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14811%2F Overall Cases Decline, but Drug-Resistant Cases a Growing Concern HARRISBURG, Pa., March 23 /PRNewswire-USNewswire/ -- In advance of World TB Day, state Health Secretary Dr. Calvin B. Johnson today stressed the need to raise public awareness of tuberculosis (TB) and the importance of efforts to control, and eventually... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510420 Fri, 30 Mar 2007 13:00:37 +0100 510420 http://www.medworm.com/index.php?rid=510421&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14810%2F ALEXANDRIA, Va., March 23 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) and Minnesota Pharmacists Association (MPhA) applauded members of the Minnesota House Health and Human Services Policy Committee on Tuesday for approving H.F.1722, critical legislation that would help preserve Medicaid patient access to pharmacy services. The state legislation would... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510421 Fri, 30 Mar 2007 12:59:20 +0100 510421 http://www.medworm.com/index.php?rid=510422&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14809%2F Patients, Advocates and Experts Applaud Positive Opinion from EU Advisory Committee--- NORTH HOLLYWOOD, Calif., and BRUSSELS, Belgium, March 23 /PRNewswire- USNewswire/ -- The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today applauded the positive... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510422 Fri, 30 Mar 2007 12:58:04 +0100 510422 http://www.medworm.com/index.php?rid=510423&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14808%2F Fundraising Event To Air on The Lifetime Network CINCINNATI, March 23 /PRNewswire-FirstCall/ -- Prilosec OTC, the number one selling over-the-counter heartburn medicine(1), is hosting the biggest Bunco party of the year with celebrity chef and entertaining expert Sandra Lee. Thousands of women from around the country will be... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510423 Fri, 30 Mar 2007 12:57:20 +0100 510423 http://www.medworm.com/index.php?rid=510424&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14807%2F MOUNTAIN VIEW, Calif., March 23 /PRNewswire-FirstCall/ -- Omnicell Inc., today announced that KLAS Enterprises has awarded Omnicell with the #1 ranking for Medication Dispensing Decentralized vendors in the "Top 20: 2006 Year-End Report Card." "We are very excited to receive this honor, which validates the hard work of... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510424 Fri, 30 Mar 2007 12:56:33 +0100 510424 http://www.medworm.com/index.php?rid=510425&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14806%2F EMEA Article 58 to speed availability in Africa's Meningitis Belt, Middle-East and North Africa RIXENSART, Belgium, March 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix(TM) (diphtheria, tetanus, pertussis, hepatitis B,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510425 Fri, 30 Mar 2007 12:39:17 +0100 510425 http://www.medworm.com/index.php?rid=510426&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14805%2F SAN DIEGO, March 29 /PRNewswire-FirstCall/ -- La Jolla Pharmaceutical Company (NASDAQ:LJPC) today announced the pricing of an underwritten public offering of 5,800,000 shares of its common stock at $6.00 per share for a total offering of $34.8 million. All of the shares are being sold by the Company. The offering... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510426 Fri, 30 Mar 2007 12:38:17 +0100 510426 http://www.medworm.com/index.php?rid=510427&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14804%2F Xyfid(TM) in Development for Hand-Foot Syndrome, a Common Side Effect Of Cancer Chemotherapy - - VQD-002-Oral Added to Pre-Clinical Pipeline - BASKING RIDGE, N.J., March 29 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals (BULLETIN BOARD: VQPH) , a New Jersey based biopharmaceutical Company focused on developing and commercializing targeted... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510427 Fri, 30 Mar 2007 12:34:57 +0100 510427 http://www.medworm.com/index.php?rid=510428&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14803%2F HOPKINS, Minn., March 29 /PRNewswire-FirstCall/ -- ... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510428 Fri, 30 Mar 2007 12:34:10 +0100 510428 http://www.medworm.com/index.php?rid=510429&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14802%2F SAN DIEGO, March 29 /PRNewswire/ -- NovaCardia, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. All shares of the common stock to be sold in this offering will be offered by... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510429 Fri, 30 Mar 2007 12:33:27 +0100 510429 http://www.medworm.com/index.php?rid=510430&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14801%2F Savel to oversee manufacturing and quality operations - FREMONT, Calif., March 29 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (NASDAQ:PDLI) today announced that Bob Savel will join the company as senior vice president of technical operations, overseeing all manufacturing and quality functions at both the company's Minnesota and California sites.... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510430 Fri, 30 Mar 2007 12:32:43 +0100 510430 http://www.medworm.com/index.php?rid=510431&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14800%2F PHILADELPHIA, March 29 /PRNewswire-FirstCall/ -- Rohm and Haas Company (NYSE:ROH) will release First Quarter 2007 earnings before the New York Stock Exchange opens on Monday, April 23, 2007. Copies of the release will be available on the news and investors sections of the company's website, www.rohmhaas.com. (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510431 Fri, 30 Mar 2007 12:32:06 +0100 510431 http://www.medworm.com/index.php?rid=510432&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14799%2F FORT WORTH, Texas, March 29 /PRNewswire/ -- H. Paul Dorman, Chairman and Chief Executive Officer of Fort Worth-based DFB Pharmaceuticals, Inc., has selected Michael E. Steadman to lead DFB Branded Pharmaceuticals, a new segment of the company that encompasses what were formerly four affiliate divisions: HEALTHPOINT(R), Ltd., Tissue Management; Coria... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510432 Fri, 30 Mar 2007 12:31:19 +0100 510432 http://www.medworm.com/index.php?rid=510433&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14798%2F New Vaccine Candidate Developed to Protect Against Cervical Cancer - Filing Includes Data from Almost 30,000 Females PHILADELPHIA, March 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced today that the company has submitted a Biologics License Application (BLA) for CERVARIX(R) (human papillomavirus vaccine, AS04 adjuvant-adsorbed), its cervical cancer candidate vaccine,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510433 Fri, 30 Mar 2007 12:30:17 +0100 510433 http://www.medworm.com/index.php?rid=510434&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14797%2F Settlement resolves all State pricing claims against DEY -- NAPA, Calif., March 29 /PRNewswire/ -- Responding to today's announcement from the State of Nevada Office of the Attorney General about the settlement between the State and Dey, L.P., John Kling, Senior Vice President of Legal Affairs at DEY,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510434 Fri, 30 Mar 2007 12:29:17 +0100 510434 http://www.medworm.com/index.php?rid=510435&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14796%2F BOSTON, March 29 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) will release Third Quarter Fiscal Year 2007 financial results on Wednesday, April 25, 2007 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com/ and on the PR Newswire website at (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510435 Fri, 30 Mar 2007 12:28:18 +0100 510435 http://www.medworm.com/index.php?rid=510436&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14795%2F CLEVELAND, March 29 /PRNewswire/ -- Athersys, Inc. today announced the company has achieved important milestones in commercial collaborations with Bristol-Myers Squibb Company (NYSE:BMY) and Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI) (NASDAQ:TSX:) (NASDAQ:ANP) , demonstrating the successful application of its technologies to drug discovery and triggering milestone-related payments. Bristol-Myers Squibb RAGE... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510436 Fri, 30 Mar 2007 12:27:37 +0100 510436 http://www.medworm.com/index.php?rid=510437&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14794%2F COURBEVOIE, France, March 29/PRNewswire-FirstCall/ -- Following the search for strategic partners for its specialty bottles business, the Saint-Gobain Group has selected the project of a consortium of two investment funds, Sagard and Cognetas. Under this agreement, the Saint-Gobain Group agreed to sell 100% of Saint-Gobain Desjonqueres and its subsidiaries. The... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510437 Fri, 30 Mar 2007 12:27:01 +0100 510437 http://www.medworm.com/index.php?rid=510438&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14793%2F KING OF PRUSSIA, Pa. and EAST KILBRIDE, Scotland, March 29 /PRNewswire/ -- Cytokine PharmaSciences, Inc. (CPSI) today announced that Cameron Macdonald, Ph.D. will become the Managing Director of the Company's wholly owned operating subsidiary, Controlled Therapeutics (Scotland) Limited (CTS). Dr. Macdonald will also be named a Vice President of CPSI. (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510438 Fri, 30 Mar 2007 12:26:12 +0100 510438 http://www.medworm.com/index.php?rid=510439&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14792%2F RALEIGH, N.C., March 29 /PRNewswire/ -- Qualyst, Inc., a leader in the development and marketing of novel and proprietary absorption, distribution, metabolism, excretion and toxicology (ADMET) technologies, today announced that orders are now being accepted for B-CLEAR(R) Kits using rat hepatocytes. B-CLEAR(R) is a proprietary, patented system that... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510439 Fri, 30 Mar 2007 12:25:32 +0100 510439 http://www.medworm.com/index.php?rid=510440&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14791%2F CRANBURY, N.J., March 29 /PRNewswire-FirstCall/ -- Innophos Holdings, Inc. (NASDAQ:IPHS) today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The dividend will be payable on April 30, 2007 to stockholders of record as of the close of business on April 13,... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510440 Fri, 30 Mar 2007 12:24:54 +0100 510440 http://www.medworm.com/index.php?rid=510441&cid=s_22558_34_f&fid=22558&url=http%3A%2F%2Fwww.drugnewswire.com%2F14790%2F CLEVELAND, March 29 /PRNewswire-FirstCall/ -- The Lubrizol Corporation (NYSE:LZ) announces the opening of a technology and commercial center in Sao Paulo, Brazil, dedicated to personal care products. The new center demonstrates Lubrizol's commitment to its customers in Brazil as well as to ongoing global expansion. Brazil, the ninth... (Source: Drug Newswire) Drug Newswire news http://www.medworm.com/rss/comments.php?id=510441 Fri, 30 Mar 2007 12:24:13 +0100 510441